Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.520
-0.040 (-1.56%)
At close: Apr 28, 2026, 4:00 PM EDT
2.530
+0.010 (0.40%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Genelux Market Cap
Genelux has a market cap or net worth of $111.82 million as of April 28, 2026. Its market cap has increased by 28.13% in one year.
Market Cap
111.82M
Enterprise Value
99.35M
1-Year Change
28.13%
Ranking
Category
Stock Price
$2.52
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $111.82M, a decrease of -21.08%. That is a compound annual growth rate of -7.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 113.59M | -30.74% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeOnc Technologies Holdings | 119.08M |
| Aardvark Therapeutics | 117.59M |
| Cardiff Oncology | 117.59M |
| Immunic | 114.82M |
| Cibus | 114.42M |
| Cognition Therapeutics | 114.37M |
| Vivani Medical | 114.27M |
| Seer, Inc. | 111.15M |